Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Bray
Jennifer McKimm-Breschkin

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The Journal of General Virology|May 23, 2001
The role of the Type I interferon response in the resistance of mice to filovirus infectionMike Bray
Antiviral Research|October 17, 2022
Antiviral Research: At age 41, a transitionMike Bray
Antiviral Research|March 5, 2003
Defense against filoviruses used as biological weaponsMike Bray
Antiviral Research|May 14, 2003
Pathogenesis and potential antiviral therapy of complications of smallpox vaccinationMike Bray
Current Opinion in Immunology|June 16, 2005
Pathogenesis of viral hemorrhagic feverMike Bray
Antiviral Research|February 5, 2008
Highly pathogenic RNA viral infections: challenges for antiviral researchMike Bray
The Lancet. Infectious Diseases|August 4, 2004
Pathogenesis of filoviral haemorrhagic feversSiddhartha Mahanty, Mike Bray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Looking back at smallpoxMike Bray, Mark Buller
Antiviral Research|March 11, 2008
Current and future antiviral therapy of severe seasonal and avian influenzaJohn Beigel, Mike Bray
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The Journal of General Virology|May 23, 2001
The role of the Type I interferon response in the resistance of mice to filovirus infectionMike Bray
Antiviral Research|October 17, 2022
Antiviral Research: At age 41, a transitionMike Bray
Antiviral Research|March 5, 2003
Defense against filoviruses used as biological weaponsMike Bray
Antiviral Research|May 14, 2003
Pathogenesis and potential antiviral therapy of complications of smallpox vaccinationMike Bray
Current Opinion in Immunology|June 16, 2005
Pathogenesis of viral hemorrhagic feverMike Bray
Antiviral Research|February 5, 2008
Highly pathogenic RNA viral infections: challenges for antiviral researchMike Bray
The Lancet. Infectious Diseases|August 4, 2004
Pathogenesis of filoviral haemorrhagic feversSiddhartha Mahanty, Mike Bray
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Looking back at smallpoxMike Bray, Mark Buller
Antiviral Research|March 11, 2008
Current and future antiviral therapy of severe seasonal and avian influenzaJohn Beigel, Mike Bray
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
Pageof 7